The announcement from Alexion is an update to a previous voluntary recall of two specific lots of Soliris asking that any unused vials at the distributor level be returned.
The two recalled lots had visible particles in the solution, posing potential immunogenicity and thromboembolic risks, according to the recall.
More Articles on Medical Recalls:
Abbott Recalls Certain Lots of FreeStyle, FreeStyle Lite Blood Glucose Test Strips
CLR Medicals International Issues Recall on Viscocel, Viscocel Plus
FDA Recalls Spacelabs Healthcare’s Anesthesia Workstations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
